Interferon signature in patients with STAT1 gain-of-function mutation is epigenetically determined
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interferon signature in patients with STAT1
gain-of-function mutation is epigenetically determined
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF IMMUNOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-02-26
DOI
10.1002/eji.201847955
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations
- (2018) Alexander Vargas-Hernández et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Aortic Calcification in a Patient with a Gain-of-Function STAT1 Mutation
- (2018) Anna E. Smyth et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation
- (2018) Markéta Bloomfield et al. JOURNAL OF CLINICAL IMMUNOLOGY
- The Potential Role of Trained Immunity in Autoimmune and Autoinflammatory Disorders
- (2018) Rob J. W. Arts et al. Frontiers in Immunology
- PD-L1 up-regulation restrains Th17 cell differentiation in STAT3 loss- and STAT1 gain-of-function patients
- (2017) Yuan Zhang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Detection of interferon alpha protein reveals differential levels and cellular sources in disease
- (2017) Mathieu P. Rodero et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Genome-wide Analysis of STAT3-Mediated Transcription during Early Human Th17 Cell Differentiation
- (2017) Subhash K. Tripathi et al. Cell Reports
- A Novel Heterozygous Mutation in the STAT1 SH2 Domain Causes Chronic Mucocutaneous Candidiasis, Atypically Diverse Infections, Autoimmunity, and Impaired Cytokine Regulation
- (2017) Kornvalee Meesilpavikkai et al. Frontiers in Immunology
- Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease
- (2017) Ofer Zimmerman et al. Open Forum Infectious Diseases
- Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype
- (2016) J. Toubiana et al. BLOOD
- AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies
- (2016) Steffen Meyer et al. CELL
- Chronic mucocutaneous candidiasis: characterization of a family with STAT-1 gain-of-function and development of anex-vivoassay for Th17 deficiency of diagnostic utility
- (2016) F. Dhalla et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Ruxolitinib Induces Interleukin 17 and Ameliorates Chronic Mucocutaneous Candidiasis Caused by STAT1 Gain-of-Function Mutation
- (2016) Rotraut Mössner et al. CLINICAL INFECTIOUS DISEASES
- Innate immune memory: Implications for host responses to damage-associated molecular patterns
- (2016) Tania O. Crișan et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Type I interferon–mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview
- (2016) Mathieu P. Rodero et al. JOURNAL OF EXPERIMENTAL MEDICINE
- g:Profiler—a web server for functional interpretation of gene lists (2016 update)
- (2016) Jüri Reimand et al. NUCLEIC ACIDS RESEARCH
- Trained immunity: A program of innate immune memory in health and disease
- (2016) M. G. Netea et al. SCIENCE
- ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization
- (2015) Guangchuang Yu et al. BIOINFORMATICS
- Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC)
- (2015) Jie Zheng et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation
- (2015) Eleanor Higgins et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Monogenic mutations differentially affect the quantity and quality of T follicular helper cells in patients with human primary immunodeficiencies
- (2015) Cindy S. Ma et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A novel gain-of-function STAT1 mutation resulting in basal phosphorylation of STAT1 and increased distal IFN-γ-mediated responses in chronic mucocutaneous candidiasis
- (2015) Laura Martinez-Martinez et al. MOLECULAR IMMUNOLOGY
- Integrative analysis of 111 reference human epigenomes
- (2015) Anshul Kundaje et al. NATURE
- Opposing roles of STAT1 and STAT3 in IL-21 function in CD4+T cells
- (2015) Chi-Keung Wan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Innate Immune Activity Is Detected Prior to Seroconversion in Children With HLA-Conferred Type 1 Diabetes Susceptibility
- (2014) H. Kallionpaa et al. DIABETES
- Two Novel Gain-of-Function Mutations ofSTAT1Responsible for Chronic Mucocutaneous Candidiasis Disease: Impaired Production of IL-17A and IL-22, and the Presence of Anti–IL-17F Autoantibody
- (2014) Yasuhiro Yamazaki et al. JOURNAL OF IMMUNOLOGY
- Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy and other primary immunodeficiency diseases help to resolve the nature of protective immunity against chronic mucocutaneous candidiasis
- (2013) Kai Kisand et al. CURRENT OPINION IN PEDIATRICS
- Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation–polyendocrinopathy–enteropathy–X-linked–like syndrome
- (2013) Gulbu Uzel et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Naive and memory human B cells have distinct requirements for STAT3 activation to differentiate into antibody-secreting plasma cells
- (2013) Elissa K. Deenick et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Simple diagnosis of STAT1 gain-of-function alleles in patients with chronic mucocutaneous candidiasis
- (2013) Y. Mizoguchi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study
- (2013) Gillian I Rice et al. LANCET NEUROLOGY
- The UCSC Genome Browser database: 2014 update
- (2013) Donna Karolchik et al. NUCLEIC ACIDS RESEARCH
- STATs Shape the Active Enhancer Landscape of T Cell Populations
- (2012) Golnaz Vahedi et al. CELL
- Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
- (2012) Caryn S. Ross-Innes et al. NATURE
- Fast gapped-read alignment with Bowtie 2
- (2012) Ben Langmead et al. NATURE METHODS
- Fast Computation and Applications of Genome Mappability
- (2012) Thomas Derrien et al. PLoS One
- An Interleukin-21- Interleukin-10-STAT3 Pathway Is Critical for Functional Maturation of Memory CD8+ T Cells
- (2011) Weiguo Cui et al. IMMUNITY
- Gain-of-function humanSTAT1mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis
- (2011) Luyan Liu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Integrative genomics viewer
- (2011) James T Robinson et al. NATURE BIOTECHNOLOGY
- STAT1Mutations in Autosomal Dominant Chronic Mucocutaneous Candidiasis
- (2011) Frank L. van de Veerdonk et al. NEW ENGLAND JOURNAL OF MEDICINE
- STAT1 Hyperphosphorylation and Defective IL12R/IL23R Signaling Underlie Defective Immunity in Autosomal Dominant Chronic Mucocutaneous Candidiasis
- (2011) Sanne P. Smeekens et al. PLoS One
- Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
- (2011) A. Puel et al. SCIENCE
- Discrete Roles of STAT4 and STAT6 Transcription Factors in Tuning Epigenetic Modifications and Transcription during T Helper Cell Differentiation
- (2010) Lai Wei et al. IMMUNITY
- GREAT improves functional interpretation of cis-regulatory regions
- (2010) Cory Y McLean et al. NATURE BIOTECHNOLOGY
- Hepatitis C and interferon induced thyroiditis
- (2009) Yaron Tomer JOURNAL OF AUTOIMMUNITY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started